[go: up one dir, main page]

MX2009008964A - Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento. - Google Patents

Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento.

Info

Publication number
MX2009008964A
MX2009008964A MX2009008964A MX2009008964A MX2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A MX 2009008964 A MX2009008964 A MX 2009008964A
Authority
MX
Mexico
Prior art keywords
ageing
vitro
genotyping
applications
product
Prior art date
Application number
MX2009008964A
Other languages
English (en)
Inventor
Antonio Martinez Martinez
Diego Tejedor Hernandez
Laureano Simon Buela
Jose Ignacio Lao Villadoniga
Original Assignee
Progenika Biopharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenika Biopharma Sa filed Critical Progenika Biopharma Sa
Publication of MX2009008964A publication Critical patent/MX2009008964A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La invención se refiere a un método "in vitro" para determinar el riesgo genético global de un sujeto a desarrollar una patología asociada al envejecimiento. Dicho método, se basa en la combinación de riesgos genéticos particulares a desarrollar patologías comunes asociadas al envejecimiento. Dichos riesgos genéticos particulares se determinan a partir de los resultados obtenidos del genotipado simultáneo de determinadas variaciones genéticas asociadas a dichas patologías asociadas al envejecimiento y, cuyo principal objetivo, es su uso en medicina anti-envejecimiento.
MX2009008964A 2007-02-23 2008-02-21 Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento. MX2009008964A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200700493 2007-02-23
PCT/ES2008/000094 WO2008102038A2 (es) 2007-02-23 2008-02-21 Método y producto para genotipado “in vitro” con aplicación en medicina anti-envejecimiento

Publications (1)

Publication Number Publication Date
MX2009008964A true MX2009008964A (es) 2009-12-01

Family

ID=39710568

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008964A MX2009008964A (es) 2007-02-23 2008-02-21 Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento.

Country Status (7)

Country Link
US (1) US20110045997A1 (es)
EP (1) EP2128275A4 (es)
AU (1) AU2008217662A1 (es)
CA (1) CA2679014A1 (es)
CO (1) CO6231055A2 (es)
MX (1) MX2009008964A (es)
WO (1) WO2008102038A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395679B1 (es) * 2009-06-17 2013-10-23 Progenika Biopharma, S.A. Método para la evaluación del comportamiento atlético de un sujeto.
JP2013162783A (ja) * 2012-01-10 2013-08-22 Arkray Inc Ｐｏｎ１遺伝子多型（ｑ１９２ｒ）を検出する方法
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
CN109074426B (zh) 2016-02-12 2022-07-26 瑞泽恩制药公司 用于检测异常核型的方法和系统
JP2019136000A (ja) * 2018-02-13 2019-08-22 国立大学法人金沢大学 冠動脈疾患の罹患リスクの判定方法又は判定の補助方法
CN108841966A (zh) * 2018-06-12 2018-11-20 广州中安基因科技有限公司 一种瘦身基因检测试剂盒
CN109355368A (zh) * 2018-10-22 2019-02-19 江苏美因康生物科技有限公司 一种快速检测高血压个体化用药基因多态性的试剂盒及方法
CN111212069B (zh) * 2019-12-31 2022-02-25 重庆邮电大学 一种5g功能开放设备接口的脆弱性评估方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200629B1 (en) * 1999-08-12 2008-01-16 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
US20030036057A1 (en) * 2001-03-09 2003-02-20 Andreas Braun Genes and polymorphisms associated with cardiovascular disease and their use
WO2003035691A1 (en) * 2001-10-26 2003-05-01 Xenon Genetics, Inc. Apolipoprotein a-i mutation useful for diagnosis and treatment of cardiovascular diseases
US20040043389A1 (en) * 2002-09-04 2004-03-04 Vitivity, Inc. Methods and compositions for identifying risk factors for abnormal lipid levels and the diseases and disorders associated therewith
WO2004085996A2 (en) * 2003-03-20 2004-10-07 Albert Einstein College Of Medicine Of Yeshiva University Biomarkers for longevity and disease and uses thereof
US20050191678A1 (en) * 2004-02-12 2005-09-01 Geneob Usa Inc. Genetic predictability for acquiring a disease or condition
EP1566449A1 (en) * 2004-02-18 2005-08-24 Max-Delbrück-Centrum Für Molekulare Medizin Use of haplotypes and SNPs in lipid-relevant genes for the analyses and diagnosis of cardiovascular diseases
US7622271B2 (en) * 2004-07-26 2009-11-24 University Of Washington Identification of aging genes through large-scale analysis
CA2612389A1 (en) * 2005-06-17 2006-12-28 Genizon Biosciences, Inc. Genemap of the human genes associated with longevity
US20080233582A1 (en) * 2005-07-26 2008-09-25 Siemens Healthcare Diagnostics Inc. Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease

Also Published As

Publication number Publication date
WO2008102038A2 (es) 2008-08-28
EP2128275A2 (en) 2009-12-02
US20110045997A1 (en) 2011-02-24
AU2008217662A1 (en) 2008-08-28
EP2128275A4 (en) 2010-12-08
CO6231055A2 (es) 2010-12-20
WO2008102038A3 (es) 2008-10-09
CA2679014A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
MX2009008964A (es) Metodo y producto para genotipado "in vitro" con aplicacion en medicina anti-envejecimiento.
JO3076B1 (ar) نظم العلاج المناعي المعتمد على حالة apoe
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
PH12013502686A1 (en) Pesticidal compositions and processes related thereto
WO2008154352A3 (en) Genetic markers associated with endometriosis and use thereof
ATE505949T1 (de) Kragen für ein tier
TW200745217A (en) Facilitating release of silicone hydrogel ophthalmic lenses
ECSP099833A (es) Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos
MX2014005096A (es) Composiciones plaguicidas y procesos relacionados con dichas composiciones.
PH12014500910A1 (en) Pesticidal compositions and processes related thereto
EP2508603A4 (en) SYSTEM FOR INCREASING GENE EXPRESSION AND VECTOR FOR SUPPORTING THIS SYSTEM
DK1999160T3 (da) Acryleret hyaluronsyre
MX2015008065A (es) Composiciones pesticidas y procesos relacionados con ellas.
AU315279S (en) Pump
WO2014076045A3 (en) Magnification loupe with display system
MX341178B (es) Metodos para determinar interacciones de gen-nutriente.
WO2010124101A3 (en) Genetic markers associated with endometriosis and use thereof
WO2008112898A3 (en) Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
EP3626830A4 (en) SINGLE NUCLEOTIDE POLYMORPHISM OF AN APOE PROMOTER RELATED TO ALZHEIMER'S MORBUS AND USE OF IT
WO2011163607A3 (en) Olfactory receptor copy number association with age at onset of alzheimer's disease
TW200734632A (en) Electrophoresis structure
FR3016888B1 (fr) Synthetases de la colistine et cluster de genes correspondants
Tseng et al. Limit order book transparency and order aggressiveness at the closing call: Lessons from the TWSE 2012 new information disclosure mechanism
EP3323776A4 (en) EMERGENCY SOLUTION SYSTEM FOR LIQUID HYDROGEN
GB2489180A (en) Method of predicting capecitabine toxicity

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: PROGENIKA BIOPHARMA, S.A.

FA Abandonment or withdrawal